A surviving beta cell subpopulation enriched in patients with T1D

Area of Science:

• Immunology
• Endocrinology
• Computational Biology

Background:

• Type 1 diabetes (T1D) involves autoimmune destruction of pancreatic beta cells.
• A subset of beta cells persists long-term in T1D, but their survival mechanisms are unclear.
• Studying these resilient cells is crucial for understanding T1D pathogenesis.

Purpose of the Study:

• To identify and characterize beta cell subtypes in patients with established T1D.
• To understand the molecular mechanisms underlying beta cell survival in the autoimmune environment of T1D.
• To explore potential therapeutic targets for T1D prevention and reversal.

Main Methods:

• Applied gene regulatory network inference and clustering to single-cell RNA sequencing data.
• Analyzed islet scRNAseq data from T1D donors, at-risk individuals, and non-diabetic controls.
• Reanalyzed public data on human beta cells stimulated with inflammatory cytokines.

Main Results:

• Identified a novel beta cell subtype enriched in T1D donors, characterized by specific transcription factor activity (e.g., IRF1).
• Observed increased expression of immunomodulatory genes (SOCS1/3, HLA-E) and decreased autoantigens/secretory genes, suggesting dedifferentiation.
• Found inflammatory cytokines drive this phenotype and identified a similar program in alpha cells, indicating inflammatory signaling.

Conclusions:

• A resilient beta cell phenotype exists in T1D, characterized by a specific transcriptional program.
• This resilient phenotype may involve dedifferentiation and immune evasion strategies.
• The identified transcriptional program could reveal novel therapeutic targets for T1D.